Top 10 A+ Setups — MPC, FANG, APA, OVV, VLO, CTRA, LNG, MRK, CAT, JNJ
Following 6 retrospectives (latest provisional grade: C): The broad market sold off sharply today — S&P 500 -1.74% to 5,477, NASDAQ -2.38%, DJI -1.01% — but the energy complex delivered a powerful counter-trend rally. E&P names surged (APA +12.5%, FANG +6.2%, OVV +7.5%, CTRA +5.6%) as Brent crude broke above $101.26 for the first time in this cycle, confirming supply tightness and geopolitical risk premium expansion. Refiners (MPC +5.3%, VLO +2.5%) continued to benefit from elevated crack spreads. Healthcare defensives (MRK +4.1%, JNJ +0.7%) attracted rotation flows as investors shed growth/tech exposure. Industrials (CAT +2.1%) held firm on infrastructure spending thesis. LNG exports (LNG +3.4%) remain a structural long as global energy security demand accelerates.
Market context: S&P 500 5,477.16 (-1.74%), NASDAQ 21,408 (-2.38%), DJI 45,960 (-1.01%), Russell 2000 2,493 (-1.70%). VIX elevated. Gold $4,376.90 (+0.01% flat), Silver $68.12 (+0.28%), WTI $93.79 (-0.73% consolidating above $93), Brent $101.26 (-0.62% above $100). DXY 99.89 (+0.29%). 10Y yield 4.416% (+2bp), 30Y 4.936%. Bitcoin $68,926 (-3.0%). European bourses weak: FTSE -1.33%, DAX -1.50%, CAC -0.98%. Asia mixed: Nikkei -0.27%, Hang Seng -1.89%.
Key catalysts: Brent crude crossed $101 — a psychologically significant level not seen since the geopolitical premium expansion. DXY hovering near 100 provides commodity support but signals persistent inflation fears. 10Y yield at 4.416% is pressuring growth equities and multiple expansion. The tape is clear: rotate out of tech/growth, lean into real assets (energy, materials, industrials) and defensives (healthcare, staples). Tomorrow's economic calendar: end-of-month rebalancing flows, potential quarter-end window dressing favoring outperforming sectors.
The regime has shifted from Early Risk-Off (March 26) to full Risk-Off as broad indices accelerated their decline. The S&P 500 shed -1.74% in a single session — the sharpest daily loss this month. NASDAQ -2.38% confirms the tech growth leadership has definitively rotated. However, the internal composition tells a nuanced story: energy sub-sectors are in a powerful breakout, defying the broader market weakness. This is classic late-cycle Risk-Off behavior — money exits overextended growth and seeks tangible real-asset exposure.
The Risk-Off regime is characterized by three simultaneous forces: (1) Growth/Tech liquidation — rising 10Y yields (4.416%) compress growth multiples, NASDAQ underperforms; (2) Energy supercycle confirmation — Brent above $100 signals structural supply deficit, E&P and services names become the new momentum leaders; (3) Defensive rotation — healthcare and staples attract institutional flows seeking earnings visibility over growth optionality. This is NOT a panic regime — it's a systematic reallocation from overvalued growth to undervalued real assets and defensives. The scanner leans heavily into this rotation with 6 energy/refining names, 2 healthcare defensives, 1 industrial, and 1 LNG structural play.
Note: The scanner's high return (127.3%) comes from asymmetric winners (avg win 17.4% vs avg loss 4.4%), not from high win rate. This confirms the tail-capture momentum strategy — few winners, but winners are large. The low win rate (28.6%) is expected and acceptable with a profit factor of 1.58 and Sharpe of 3.48.
Currently tracking 31 open positions from recent scans. Tickers excluded from today's selection to avoid overlap:
⚠️ Heavy energy concentration in existing book — today's new selections diversify into refining, LNG, healthcare, and industrials rather than adding more E&P integrated majors.
| # | Ticker | Company | Sector | Strategy | Score | Entry | Stop | TP1 | TP2 | R/R |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MPC | Marathon Petroleum | Refining | Breakout | 93 | $246–$250 | $235 | $270 | $290 | 1:1.7 |
| 2 | FANG | Diamondback Energy | E&P | Breakout | 91 | $200–$204 | $190 | $220 | $240 | 1:1.6 |
| 3 | APA | APA Corporation | E&P | Momentum | 90 | $41–$43 | $38 | $48 | $53 | 1:1.6 |
| 4 | OVV | Ovintiv | E&P | Breakout | 89 | $60–$62 | $56 | $68 | $74 | 1:1.5 |
| 5 | VLO | Valero Energy | Refining | Trend Follow | 88 | $245–$250 | $234 | $268 | $285 | 1:1.5 |
| 6 | CTRA | Coterra Energy | E&P | Breakout | 88 | $35–$36 | $33 | $40 | $44 | 1:1.7 |
| 7 | LNG | Cheniere Energy | LNG | Trend Follow | 87 | $288–$293 | $275 | $315 | $340 | 1:1.5 |
| 8 | MRK | Merck & Co. | Healthcare | Defensive Momentum | 87 | $117–$120 | $112 | $128 | $135 | 1:1.6 |
| 9 | CAT | Caterpillar | Industrials | Trend Follow | 86 | $695–$705 | $670 | $740 | $775 | 1:1.4 |
| 10 | JNJ | Johnson & Johnson | Healthcare | Defensive | 85 | $237–$240 | $228 | $252 | $265 | 1:1.4 |
Marathon Petroleum surged +5.31% today to $248.31, approaching its 52-week high of $252.40 on a day when the broad market collapsed. This is the strongest possible relative strength signal. MPC is the largest independent refiner in the US, operating 13 refineries with 2.9 million bpd of crude throughput capacity. With WTI at $93.79 and Brent at $101.26, crack spreads remain highly elevated — refiners capture the spread between crude input costs and refined product output prices. The gasoline and diesel crack spread is currently running at multi-year highs as refined product inventories are below seasonal norms. MPC's Gulf Coast complex in particular benefits from cheap domestic crude (WTI discount to Brent at ~$7.47/bbl). The +5.31% surge on a -1.74% S&P day represents a 7.05% relative outperformance — institutional money is actively rotating into this name. Price is 13.5% above its 50-day MA ($218.70), confirming structural uptrend without being dangerously overextended.
Diamondback Energy exploded +6.24% to $202.19 — a monster move on a deeply red tape. FANG is the premier pure-play Permian Basin E&P, with the lowest-cost production in the most prolific US oil basin. At $93.79 WTI, Diamondback generates massive free cash flow — breakeven sits near $45/bbl, meaning every dollar above that is essentially pure margin. The company's capital discipline is exemplary: returning 75%+ of FCF to shareholders via variable dividends and buybacks while maintaining flat-to-low production growth. The +6.24% move on a -1.74% S&P day represents 7.98% relative outperformance. FANG is approaching its 52W high of ~$210, and a breakout above that level would confirm a new uptrend leg. The 13.3% premium to MA50 ($178.50) is well within the healthy trend range. Permian Basin well productivity continues to improve, and FANG's completion efficiency leads the industry. With Brent above $101, FANG's export-grade crude commands premium pricing.
APA Corporation delivered the strongest move on the board today: +12.45% to $42.80, a parabolic surge that puts it within striking distance of its 52-week high ($45.50). APA operates a diversified E&P portfolio across the US Permian Basin, Egypt (via Western Desert assets), and the North Sea (via Calvalley/Suriname deepwater). This geographic diversification is actually a strength in the current environment — Brent above $101 means the international portfolio is generating outsized returns, while Permian operations benefit from WTI at $93.79. The +12.45% single-day move is exceptional and likely driven by institutional block buying or a catalyst (potential asset sale announcement, production beat, or M&A speculation). The stock is 20.2% above its MA50 ($35.60) — getting extended, but the momentum signal is undeniable. Price is approaching 52W highs near $45.50 — a breakout above would confirm a major trend reversal from the lows of $18.20.
Ovintiv surged +7.51% to $61.26, continuing a powerful breakout in the multi-basin E&P space. OVV operates across the Permian, Anadarko (STACK/SCOOP), and Montney basins, providing diversified exposure to both oil and natural gas. At $93.79 WTI, Ovintiv's oil-weighted Permian portfolio generates strong FCF, while the Montney gas assets provide optionality to LNG export demand. The company has dramatically improved its balance sheet, reducing net debt from $8B+ to under $3B, unlocking enhanced capital return capacity. OVV's +7.51% move on a -1.74% S&P day represents 9.25% relative outperformance. Price is 16% above MA50 ($52.80) — extended but within breakout parameters. The 52W high at $65 is within reach, and a close above would open up significant technical upside.
Valero Energy, the world's largest independent petroleum refiner, gained +2.51% to $248.14 — steady strength on a brutal market day. VLO operates 15 refineries across the US, Canada, and UK with a total throughput capacity of 3.2 million bpd. The company's refining complexity advantage means it can process heavier, cheaper crude grades (like Canadian heavy) and extract maximum margin through its coking and cracking units. Crack spreads are the lifeblood of refining economics: the current Gulf Coast 3-2-1 crack spread is running above historical averages as refined product inventories (gasoline, diesel, jet fuel) remain below 5-year seasonal norms. VLO's renewable diesel segment (Diamond Green Diesel JV) adds an ESG-compatible earnings stream. The WTI-Brent spread at $7.47/bbl directly benefits VLO's Gulf Coast operations, which source cheaper WTI-linked crude. Price is 12.8% above MA50 — confirmed uptrend with room to run.
Coterra Energy surged +5.58% to $35.79, continuing the E&P breakout theme. CTRA is unique in the E&P space — it operates a dual-basin model with significant acreage in both the Permian Basin (oil) and Marcellus Shale (gas). This dual commodity exposure is a strategic advantage: when oil prices are strong (like now at $93.79), the Permian portfolio drives earnings; when gas recovers (via LNG export demand or winter heating), the Marcellus portfolio provides upside optionality. CTRA was formed from the Cabot-Cimarex merger, combining Cabot's premier Marcellus gas position with Cimarex's Permian oil assets. The company maintains one of the strongest balance sheets in E&P — net debt-to-EBITDA below 0.5x — providing exceptional financial flexibility. The +5.58% move puts CTRA 16.2% above its MA50 ($30.80) and within 5.8% of its 52W high ($38.00). The stock trades at a significant discount to pure-play Permian peers on EV/EBITDA, creating a valuation re-rating opportunity.
Cheniere Energy gained +3.38% to $291.40, continuing its structural uptrend as the dominant US LNG exporter. LNG is a secular growth story — global LNG demand is projected to grow 50%+ by 2030 as Europe diversifies away from Russian pipeline gas, Asia grows energy demand, and emerging markets transition from coal to gas. Cheniere operates the Sabine Pass and Corpus Christi LNG terminals, representing ~45% of total US LNG export capacity. The company's contracted revenue model provides exceptional earnings visibility — 85%+ of capacity is under long-term contracts (15-20 year) with investment-grade counterparties. At $291.40, LNG is 10% above its MA50 ($265.00) — healthy uptrend territory. With Brent above $101, the JKM-HH spread (Asian LNG benchmark minus US gas) remains wide, driving maximum export economics. Cheniere's Stage 3 expansion at Corpus Christi adds 10 MTPA of capacity — visible growth through 2027-2028.
Merck surged +4.14% to $118.93 on a deeply negative market day — classic defensive rotation behavior. When the S&P drops -1.74% and a $300B+ pharma giant gains +4.14%, that's a 5.88% relative outperformance signal that institutional investors are aggressively seeking safety in earnings quality. Merck's crown jewel is Keytruda — the world's best-selling oncology drug with $25B+ in annual sales and expanding label across 30+ cancer types. The Keytruda franchise is the most valuable pharma asset in the world, and Merck is actively building its pipeline to extend the franchise through combinations, subcutaneous formulations, and next-gen immunotherapies. Beyond Keytruda, Merck's animal health division (Organon spin-off complete) and vaccine portfolio (Gardasil, Pneumovax) provide diversified revenue streams. At $118.93, MRK is 12.7% above MA50 ($105.50) — a healthy uptrend with defensive characteristics. The stock is approaching its 52W high of $125, and a breakout would signal sustained defensive leadership in the Risk-Off regime.
Caterpillar advanced +2.11% to $703.19 against a weak tape, reinforcing its status as the bellwether for global infrastructure and resource spending. CAT is the world's largest manufacturer of construction and mining equipment, diesel-electric locomotives, and industrial gas turbines. Three structural tailwinds drive the thesis: (1) US infrastructure spending — the Infrastructure Investment and Jobs Act is deploying $1.2T over 10 years, with peak spending years still ahead; (2) Global mining capex cycle — rising commodity prices (copper $5.47/lb, gold $4,377, iron ore recovering) drive mining equipment demand; (3) Energy transition paradox — building renewable infrastructure (solar farms, wind farms, battery plants) requires massive earthmoving equipment. At $703.19, CAT is 8.2% above MA50 ($650) — moderate uptrend with room for continuation. The stock approaches its 52W high of $720, with institutional ownership increasing steadily.
Johnson & Johnson eked out a +0.69% gain to $239.24 on a -1.74% S&P day — a 2.43% relative outperformance that demonstrates classic defensive behavior. Post-Kenvue spinoff, JNJ is now a focused pharmaceutical and medtech company, shedding its consumer health drag. The new JNJ is more comparable to Merck or Abbott than to the old diversified conglomerate. Key franchises include Stelara (immunology), Darzalex (oncology), Tremfya (psoriasis), and a world-class medtech portfolio (surgical robotics via Ottava, orthopedics, vision care). JNJ's medtech segment is experiencing strong organic growth driven by post-COVID procedure recovery and robotic surgery adoption. With a 2.6% dividend yield and 62 consecutive years of dividend increases (Dividend King status), JNJ is the quintessential Risk-Off shelter. At $239.24, the stock is 7.8% above MA50 ($222) — moderate uptrend with low volatility. A close above $245 (52W high) would confirm institutional commitment to the defensive rotation.
The MarketWatch Scanner combines quantitative screening (RSI, MACD, volume ratios, ATR-based stops, MA positioning) with qualitative regime analysis (market regime, sector rotation, macro context, catalyst calendar). Each setup is scored on a 0-100 scale incorporating:
Backtest model: 30 positions max, 1/30 capital per trade. Entry at next-day open within the entry range. Stop loss triggered intraday. Take profit targets monitored at close. Position held max 25 trading days.
Exclusions applied: All 31 open positions excluded from selection. Short Squeeze setups filtered out per scanner policy.
This is NOT investment advice. The MarketWatch Scanner is an educational and analytical tool. All trade setups are hypothetical and based on technical/fundamental screening models. Past performance does not guarantee future results. The scanner's backtest shows a 28.6% win rate with a 1.58 profit factor — most trades lose, but winners are significantly larger than losers. Always do your own research, consult a licensed financial advisor, and never risk more than you can afford to lose. Market conditions can change rapidly, and stop losses can gap through in extreme volatility. Position sizes should be managed according to your personal risk tolerance and portfolio size.
Conflict of interest: The author may hold positions in the securities discussed. This content is generated by algorithmic screening and AI-assisted analysis.